NUCRYST Pharmaceuticals Corp. (NCS.TO) Buy,…

NUCRYST Pharmaceuticals Corp. (NCS.TO)

0.00

-0.00 (0.00%)

0 watching

DON'T BUY

Their acne treatment was not approved previously by the FDA, but suddenly was in July.. The approval isn’t doing a great deal for it.

PAST TOP PICK

(A Top Pick Aug 24/06. Down 79.5%.) Their cream for treating acne did not get approved by the FDA, but did get approval 2 weeks ago. It might still be interesting. Sold his holdings.

PAST TOP PICK

(A Top Pick Aug 24/06. Down 52%.) Something went wrong with silver ointment treatment. They are back with silver bandaging. Based on the bandaging, it will be trading at 8-9 X earnings.

TOP PICK

The Silcryst bandaging spin off from Westaim (WED-T). (They still hold about 75%). Have developed/patented a technology for reducing nanotechnology silver to its crystalline level for application in ointments. Getting great revenues. Highly speculative.

Showing 1 to 4 of 4 entries

Most Recent Experts

Andrew Pink

LDIC

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Greg Newman

Scotia Wealth Management

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Jim Cramer - Mad Money

CNBC

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

NUCRYST Pharmaceuticals Corp. (NCS.TO) Frequently Asked Questions

What is NUCRYST Pharmaceuticals Corp. stock symbol?

NUCRYST Pharmaceuticals Corp. is a OTC stock, trading under the symbol NCS.TO (previously NCS-T on Stockchase) on the undefined (undefined). It is usually referred to as or NCS.TO

Is NUCRYST Pharmaceuticals Corp. a buy or a sell?

In the last year, no analyst issued a Buy, Sell, or Hold rating on NCS.TO (previously NCS-T on Stockchase) on Stockchase. Read the latest expert commentary for NUCRYST Pharmaceuticals Corp..

Is NUCRYST Pharmaceuticals Corp. a good investment or a top pick?

NUCRYST Pharmaceuticals Corp. was recommended as a Top Pick by Michael Smedley on 2007-09-24. Read the latest stock experts ratings for NUCRYST Pharmaceuticals Corp..

Why is NUCRYST Pharmaceuticals Corp. stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for NUCRYST Pharmaceuticals Corp..

Is NUCRYST Pharmaceuticals Corp. worth watching?

NUCRYST Pharmaceuticals Corp. is covered by Stockchase experts and is worth watching.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

NUCRYST Pharmaceuticals Corp. (NCS.TO)